Medical device companies lose deals they should win because they do not understand how purchase decisions are actually made inside health systems. The sales team talks to the physician champion. The physician champion advocates internally. The deal dies in a committee meeting the sales team was not invited to, killed by a procurement objection, a biomedical engineering concern, or a nursing workflow argument the device company never heard.
Understanding the full buying committee — who participates, what each role evaluates, how influence flows, and where deals break — is the difference between a sales strategy built on clinical evidence and a sales strategy built on clinical evidence that is also politically viable.
The Buying Committee Map
The Clinical Champion (Physician/Surgeon)
Decision lens: Clinical outcomes, patient safety, ergonomics, procedural efficiency Influence type: Initiator and advocate. Generates demand and provides clinical justification. Interview focus: What clinical need prompted the evaluation? How does this device compare to current alternatives in your hands? What would make you switch from your current device? What clinical evidence do you need to justify the change?
Department Head / Division Chief
Decision lens: Department performance, resource allocation, physician satisfaction, clinical outcomes Influence type: Authority to approve or block within the clinical domain Interview focus: How does this request fit with department priorities? What competing resource demands exist? How do you evaluate the trade-off between clinical improvement and cost?
Hospital Administrator / VP Operations
Decision lens: Financial impact, ROI, operational efficiency, strategic alignment Influence type: Budget authority. Often the decision-maker for purchases above a threshold. Interview focus: What is the business case threshold for this category of purchase? How do you evaluate ROI for clinical technology? What information do you need from the vendor that you rarely receive?
Procurement Director
Decision lens: Vendor terms, compliance, contract structure, supply chain reliability Influence type: Process gatekeeper. Cannot approve but can effectively veto through procedural requirements. Interview focus: What vendor compliance requirements create the most friction? What contract terms are non-negotiable? Where do device evaluations typically stall in the procurement process?
Biomedical Engineering
Decision lens: Technical specifications, integration with existing infrastructure, maintenance requirements, training burden Influence type: Technical evaluator. Can raise concerns that delay or block purchases. Interview focus: What technical evaluation criteria do you apply? How do you assess integration risk? What device failures have you experienced that shape your evaluation of new technology?
Nursing Leadership
Decision lens: Clinical workflow impact, training requirements, patient safety, staff acceptance Influence type: Workflow authority. Devices that nurses cannot or will not use fail regardless of clinical promise. Interview focus: How does this device change the clinical workflow? What training would be required? How do you assess whether nursing staff will adopt a new device?
Multi-Stakeholder Interview Design
The most valuable procurement research interviews each stakeholder role separately about the same purchase decision. Each role reveals different dimensions of the decision:
- The physician describes clinical need and competitive differentiation
- The administrator describes financial justification and strategic fit
- Procurement describes process barriers and vendor evaluation
- Biomedical engineering describes technical concerns and integration risk
- Nursing describes workflow impact and adoption probability
When you triangulate these perspectives, you see the full decision architecture — including the disconnects between what physicians advocate for and what administrators approve, or between what vendors promise and what biomedical engineering expects.
AI-moderated interviews on platforms like User Intuition enable this multi-stakeholder approach at scale. Instead of conducting 5-10 interviews for a single deal, you can interview the buying committee across 10-20 deals to identify systematic patterns in how your devices win or lose.
Win-Loss Analysis for Device Companies
Post-decision interviews with buying committee members reveal why deals actually closed or were lost — information that CRM notes and sales team debriefs consistently misrepresent.
Win interviews surface what created conviction across the committee, which evidence or demonstration was pivotal, and what almost derailed the deal. This intelligence shapes sales enablement and clinical evidence strategy.
Loss interviews surface the real objections (vs. the polite rejection the sales team received), where competitive alternatives won on specific dimensions, and which stakeholder’s concerns were unaddressed. This intelligence shapes product development, pricing, and competitive positioning.
Running win-loss analysis through AI-moderated interviews at scale (20-50 deals per quarter) produces pattern-level intelligence: systematic strengths to lean into, systematic weaknesses to address, and systematic competitive dynamics to counter.
Building Procurement Intelligence
Episodic procurement research produces deal-level insights. Continuous research builds institutional understanding of how health system purchasing works. Over multiple quarters of buying committee interviews, device companies develop:
- Decision-process maps for different institution types (academic medical centers, community hospitals, ambulatory surgery centers)
- Stakeholder influence patterns by device category and price point
- Objection libraries with counter-strategies by role
- Competitive intelligence on how alternatives are positioned and perceived
- Timing patterns for when in the budget cycle different device categories are evaluated
This cumulative intelligence, stored in a searchable Intelligence Hub, gives sales, marketing, and product teams a structural advantage: they understand how their customers make decisions at a depth that competitors operating on anecdotal sales feedback cannot match.